23 Followers on Owler

Neurogene

is a pharmaceutical company that develops and commercializes genetic medicines for the treatment of neurological diseases... Read more
OverviewCompetitorsFundingNews & Insights

Neurogene

is a pharmaceutical company that develops and commercializes genetic medicines for the treatment of neurological diseases... Read more
Neurogene CEO: Rachel McMinn

CEO

Rachel McMinn

CEO Approval Rating

88/100

2018

PublicMerged with Neoleukin Therapeutics, Inc.NASDAQNGNE

Pharmaceuticals & Biotechnology
Pharmaceuticals
28342836 NAICS listing

Annual Revenue
<$1M
Employees
90
Funding
$527.2M

News

Funding
Jul 20, 2026
globallegalchronicle
Neurogene received $143.7M in Post-IPO Equity Funding

Neurogene Competitors

1NeuroNascent
2Neurona
3Denali Therapeutics
4Brainstorm Cell Therapeutics
5Aqua Serv
6Maryland Select Homes
7ProMIS Neurosciences
Unlock 4 + competitors

Trending Companies